Jones Financial Companies Lllp Lucid Diagnostics Inc. Transaction History
Jones Financial Companies Lllp
- $111 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,010 shares of LUCD stock, worth $1,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,010
Previous 40,000
97.48%
Holding current value
$1,171
Previous $59,000
98.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LUCD
# of Institutions
50Shares Held
9.49MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$3.16 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$2.19 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$1.03 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$532,5150.0% of portfolio
-
Luminus Management LLC Houston, TX457KShares$529,7070.62% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $44.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...